AIRLINK 73.20 Increased By ▲ 0.20 (0.27%)
BOP 5.44 Increased By ▲ 0.09 (1.68%)
CNERGY 4.34 Increased By ▲ 0.03 (0.7%)
DFML 27.84 Decreased By ▼ -0.71 (-2.49%)
DGKC 77.40 Increased By ▲ 3.11 (4.19%)
FCCL 20.75 Increased By ▲ 0.40 (1.97%)
FFBL 31.45 Increased By ▲ 0.55 (1.78%)
FFL 10.15 Increased By ▲ 0.09 (0.89%)
GGL 10.47 Increased By ▲ 0.08 (0.77%)
HBL 116.50 Increased By ▲ 0.53 (0.46%)
HUBC 138.11 Increased By ▲ 5.91 (4.47%)
HUMNL 6.71 Increased By ▲ 0.03 (0.45%)
KEL 4.21 Increased By ▲ 0.18 (4.47%)
KOSM 4.80 Increased By ▲ 0.20 (4.35%)
MLCF 39.20 Increased By ▲ 0.66 (1.71%)
OGDC 135.57 Increased By ▲ 1.72 (1.29%)
PAEL 23.90 Increased By ▲ 0.07 (0.29%)
PIAA 27.65 Increased By ▲ 0.52 (1.92%)
PIBTL 6.95 Increased By ▲ 0.19 (2.81%)
PPL 113.99 Increased By ▲ 1.19 (1.05%)
PRL 28.15 Decreased By ▼ -0.01 (-0.04%)
PTC 14.96 Increased By ▲ 0.07 (0.47%)
SEARL 57.14 Increased By ▲ 0.72 (1.28%)
SNGP 65.95 Increased By ▲ 0.15 (0.23%)
SSGC 11.07 Increased By ▲ 0.06 (0.54%)
TELE 9.07 Increased By ▲ 0.05 (0.55%)
TPLP 11.94 Increased By ▲ 0.04 (0.34%)
TRG 69.90 Increased By ▲ 0.80 (1.16%)
UNITY 23.86 Increased By ▲ 0.15 (0.63%)
WTL 1.36 Increased By ▲ 0.03 (2.26%)
BR100 7,546 Increased By 111.3 (1.5%)
BR30 24,674 Increased By 454.6 (1.88%)
KSE100 72,399 Increased By 1039.9 (1.46%)
KSE30 23,945 Increased By 378 (1.6%)

imageTOKYO: Researchers in Japan have been unable to replicate experiments that were hailed earlier this year as a "game-changer" in the quest to grow transplant tissue, amid claims evidence was faked, a report said Wednesday.

In a scandal that rocked Japan's scientific establishment, Riken -- a research institute that sponsored the study -- launched an independent experiment in April to verify research published by scientist Haruko Obokata and her colleagues earlier this year.

But the struggle to replicate the experiment casts further doubt on the existence of stem cell-like cells, what the researchers called Stimulus-Triggered Acquisition of Pluripotency (STAP) cells, Japan's Nikkei daily reported.

Obokata was feted after unveiling findings that appeared to show a straightforward way to re-programme adult cells to become stem cells -- precursors that are capable of developing into any other cell in the human body.

Identifying a readily manufacturable supply of stem cells could one day help meet a need for transplant tissues, or even whole organs, meaning that any advance in the field is met with excitement in the scientific community.

But after being accused of fabricating results, she agreed to retract papers published in the respected journal Nature.

Earlier this month, Obokata's co-author, stemcell scientist Yoshiki Sasai, hanged himself.

Researchers have been trying to replicate results appearing to show that exposing ordinary cells to various stresses had made them pluripotent, or able to differentiate into any type of tissue.

Riken had planned to implant these cells into mouse embryos to test whether they really were pluripotent.

But the experiments have been fraught with difficulty from the outset, with researchers unable to reproduce such cells, the Nikkei said, citing unnamed sources.

Obokata has been trying in tandem to reproduce her own results since July, but the existence of the STAP cells at this point looks highly doubtful, the Nikkei said.

Riken is to release an interim report on the follow-up study and announce a shake-up of the developmental biology centre in a Wednesday news conference, where it is expected to slash its staff of around 400 researchers by half.

Copyright AFP (Agence France-Presse), 2014

Comments

Comments are closed.